Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).

Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).

Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein grafts.

Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions.

Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.

Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.

Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.

Aspirin sensitivity: implications for patients with coronary artery disease.